SOPHiA GENETICS CEO sells 5,100 shares for taxes

SOPHiA GENETICS SA Chief Executive Officer Jurgi Camblong sold a total of 5,100 Ordinary Shares of the company in early April 2026.

Rhea-AI Filing Summary

SOPHiA GENETICS SA Chief Executive Officer Jurgi Camblong sold a total of 5,100 Ordinary Shares of the company in early April 2026. The transactions were open‑market sales made solely to cover tax withholding obligations triggered by the vesting of restricted stock units on April 2 and 3, 2026, under a pre‑established Rule 10b5‑1 trading plan and were not discretionary trades. Camblong sold 2,600 shares on April 6 at a weighted average price of $4.8517 and 2,500 shares on April 7 at a weighted average price of $4.8619, and continued to hold about 3.73 million Ordinary Shares directly after these sales.

Insider Trade Summary 10b5-1

Net Seller: 5,100 shares

Net Sell 2 txns

Insider Camblong Jurgi

Role Chief Executive Officer

Sold 5,100 shs ($25K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	2,500	$4.8619	$12K
Sale	Ordinary Shares	2,600	$4.8517	$13K

Holdings After Transaction: Ordinary Shares — 3,728,950 shares (Direct)

Footnotes (3)

1. F1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
2. F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.71 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.69 to $4.98, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Total shares sold: 5,100 shares Shares sold on April 6, 2026: 2,600 shares Weighted average price April 6: $4.8517 per share +3 more

6 metrics

Total shares sold 5,100 shares Open-market sales in early April 2026

Shares sold on April 6, 2026 2,600 shares Ordinary Shares, open-market sale

Weighted average price April 6 $4.8517 per share Ordinary Shares sale on April 6, 2026

Shares sold on April 7, 2026 2,500 shares Ordinary Shares, open-market sale

Weighted average price April 7 $4.8619 per share Ordinary Shares sale on April 7, 2026

Shares held after April 7 sale 3,728,950 shares Direct ownership of Ordinary Shares

Key Terms

restricted stock units, tax withholding obligations, Rule 10b5-1 trading plan, weighted average price

4 terms

restricted stock units financial

"arising in connection with the vesting of restricted stock units on April 2 and 3, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection"

Rule 10b5-1 trading plan regulatory

"These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SOPHiA GENETICS (SOPH) report for its CEO?

SOPHiA GENETICS reported that CEO Jurgi Camblong sold 5,100 Ordinary Shares in early April 2026. These open‑market sales were made solely to satisfy tax withholding obligations from recent RSU vesting and were executed under a pre‑established Rule 10b5‑1 trading plan.

On what dates did SOPHiA GENETICS CEO Jurgi Camblong sell shares?

CEO Jurgi Camblong sold Ordinary Shares on April 6 and April 7, 2026. He disposed of 2,600 shares on April 6 and 2,500 shares on April 7, with both transactions reported as open‑market sales linked to RSU tax withholding obligations.

At what prices were SOPH CEO Jurgi Camblong’s shares sold?

The April 6, 2026 sale used a weighted average price of $4.8517 per share, while the April 7 sale used $4.8619 per share. Each represents the average of multiple trades within intraday price ranges disclosed in the accompanying footnotes.

How many SOPHiA GENETICS shares does the CEO hold after these sales?

After the April 7, 2026 transaction, CEO Jurgi Camblong directly holds 3,728,950 Ordinary Shares. This post‑transaction figure shows that the 5,100 shares sold to cover tax withholding represent a small portion of his overall direct ownership stake.

Were SOPH CEO Jurgi Camblong’s share sales discretionary transactions?

No. The filing explains that the sales were made to satisfy tax withholding obligations from RSU vesting and occurred under a pre‑established Rule 10b5‑1 trading plan. This means the trades were pre‑scheduled and not discretionary timing decisions by the CEO.

Why did SOPHiA GENETICS’ CEO sell 5,100 shares instead of keeping them?

The CEO sold 5,100 shares to cover tax withholding obligations tied to vested restricted stock units. Instead of paying taxes in cash, a portion of shares is sold in the market, a common administrative practice for equity compensation, leaving the remaining shares still held.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/08/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Camblong Jurgi

(Last) (First) (Middle)

C/O SOPHIA GENETICS SA

LA PIECE 12

(Street)

ROLLE 1180

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/06/2026		S		2,600(1)	D	$4.8517(2)	3,731,450	D
Ordinary Shares	04/07/2026		S		2,500(1)	D	$4.8619(3)	3,728,950	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.71 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.69 to $4.98, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Elimara Brunetto as Attorney-in- Fact for Jurgi Camblong	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)